Olga A. Partington, Ph.D.

Director

opartington@sternekessler.com
+1 202.772.8626
LinkedIn

Overview

Olga A. Partington, Ph.D., is a director in Sterne Kessler’s Biotechnology & Chemical Practice Group. Olga has substantial experience in inter partes review proceedings. In addition, she has been involved in several other contested proceedings before the USPTO, such as inter partes re-examinations and interferences.

Olga also has extensive experience in drafting patentability, infringement, and validity opinions, and in working with technical experts. She also has experience in assisting clients in designing around patents, and has been involved in pharmaceutical patent litigations brought under the Hatch-Waxman Act. Her practice also includes domestic and foreign patent prosecution, particularly chemical patents. She also has experience in counseling clients on patentability strategies.

Olga gained extensive technical experience in the areas of nucleic acid chemistry, organic, bioinorganic, and biological chemistry, enzymology, and spectroscopy in the laboratories of Dr. Sheila David and Nobel Prize laureate Dr. Paul Modrich. She earned her J.D. from The Catholic University of America Columbus School of Law, her Ph.D. and her B.S. in chemistry from the University of Utah.

Technical Publications

  • Engstrom LM, Partington OA, David SS. Biochemistry.2012 Jun 26;51(25):5187-97. Epub 2012 Jun 12. “An Iron-Sulfur Cluster Loop Motif in the Archaeoglobus fulgidus Uracil-DNA Glycosylase Mediates Efficient Uracil Recognition and Removal.”
  • Pluciennik A, Burdett V, Lukianova O, O’Donnell M, Modrich P. J Biol Chem. 2009 Nov 20;284(47):32782-91. Epub 2009 Sep 25. “Involvement of the beta clamp in methyl-directed mismatch repair in vitro.”
  • Kadyrov FA, Holmes SF, Arana ME, Lukianova OA, O’Donnell M, Kunkel TA, Modrich P. J Biol Chem. 2007 Dec 21;282(51):37181-90. Epub 2007 Oct 19.”Saccharomyces cerevisiae MutLalpha is a mismatch repair endonuclease.”
  • Boal, A.K., Yavin, E., Lukianova, O.A., O’Shea, V.L., David, S.S., Barton, J.K., “DNA- Bound Redox Activity of DNA Repair Glycosylases Containing [4Fe-4S] Clusters” (2005) Biochemistry, 44(23); 8397- 8407
  • Lukianova, O.A., David, S.S., “A Role for [4Fe- 4S] Clusters in DNA Repair”, (2005) Curr. Opin. Chem. Biol.,9(2); 145-151.
  • Chepanoske, C. L., Lukianova, O. A., Lombard, M., Golinelli-Cohen, M.-P., and David, S. S., “A Residue in MutY Important for Catalysis Identified by Photocross- Linking and Mass Spectrometry” (2004) Biochemistry, 43(3); 651-662

Education

  • J.D., The Catholic University of America Columbus School of Law
  • Ph.D., Chemistry, University of Utah
  • B.S., Chemistry, University of Utah

Admissions

  • District of Columbia
  • United States Patent & Trademark Office
  • Utah

Languages Spoken

  • Russian
  • Ukrainian

Events

Speaking Engagement 2023 Focus on Pharma Washington, DC, April 14, 2023
Speaking Engagement Microbiome R&D and Business Collaboration Forum: USA San Diego, CA, October 29, 2018

Related Resources From Olga A. Partington, Ph.D.

In the News PTAB Denies Review Of Univ. Of Texas System Cancer Patent Law360 November 27, 2023
Firm Announcements Sterne Kessler Secures Denial of PGR for Largest Cancer Center in the US Sterne, Kessler, Goldstein & Fox November 27, 2023
Press Release Sterne Kessler Elects Record-High Seven Directors in 2023 Sterne, Kessler, Goldstein & Fox January 4, 2023
In the News Almirall Loses Appeal on Acne Treatment Patent at Fed. Cir. Bloomberg Law March 14, 2022
In the News Fed. Circ. Affirms PTAB's Ax of Acne Drug Patent Law360 March 14, 2022
Press Release Sterne Kessler Publishes 2021 PTAB Year in Review: Analysis & Trends Report Sterne, Kessler, Goldstein & Fox March 7, 2022
Press Release Sterne Kessler Elects Three New Directors and Promotes Five Attorneys to Counsel Sterne, Kessler, Goldstein & Fox P.L.L.C. January 2, 2020
In the News Teva Gets PTAB To Review Cushing's Syndrome Drug Patent Law360 November 21, 2019
In the News ImmunoGen Cancer Patent Still Valid After Phigenix's Dispute Bloomberg BNA October 29, 2015
In the News PTAB Upholds ImmunoGen’s Breast Cancer Drug Patent Law360 October 28, 2015